Judge Zahid Quraishi found no irreparable harm, though Novo's false advertising suit goes on. New REDEFINE 1 analyses split results by menopause status.
Recap by typeshit. Full story at ad-hoc-news.de.
Per @pamelajeannoble, the letter flags contamination risks, manufacturing conditions and compounded copies resembling approved drugs.
Gounder notes the policy requires no testing of finished vials or deadline for side effect reports, and public comments on the draft run through November 13.
Healio
Durrani tells Healio the move bypassed rulemaking and FDA scientists, and warns patients may wrongly read it as FDA approval while long-term data is missing.
AP sources say FDA scientists opposed the HHS draft telling the agency not to act against pharmacies compounding six wellness peptides. Comments are open for two weeks.
NewBeauty talks with New York plastic surgeon Dr. Anna Steve about how common GLP-1 use has become among the people coming to her practice.
The Select Committee on China cites reports of bug-infested, mold-covered plants producing GLP-1 ingredients and warns about weak oversight in Chinese supply chains.
Loading…